What does SciMedBE do?

SciMedBE is a research organisation in Leuven. Private Limited, started on 26 April 2016, 1 establishment.

What is the address of SciMedBE?

The registered office of SciMedBE is located at Slachthuislaan 1 box 102, 3000 Leuven.

Is SciMedBE still active?

Yes. According to the CBE (30 October 2026) SciMedBE is active, legal situation “Normale toestand”, started on 26 April 2016.

Is SciMedBE registered on Peppol?

Yes, SciMedBE is registered on the Peppol network with ID 0208:0652860676.

What is the enterprise number of SciMedBE?

The enterprise number of SciMedBE is BE0652860676.

When was SciMedBE founded?

SciMedBE was founded on 26 April 2016.

Who are the directors of SciMedBE?

According to the 2025 annual accounts, the directors of SciMedBE are: Admir Hadzic.

Is SciMedBE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 April 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SciMedBE make in 2025?

SciMedBE posted a profit after taxes of € 6,606 in financial year 2025.

What is the revenue of SciMedBE?

As a small company, SciMedBE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 356,779.

SciMedBE (Private Limited) - Leuven - BE0652860676

Dossier SciMedBE, printed on 30 October 2026 from databakkes.be/en/0652860676/scimedbe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 14 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

SciMedBE from Leuven, company number BE0652860676, closed financial year 2025 with a result of € 6,606 after tax. For that financial year SciMedBE recorded a gross margin of € 356,779 and equity of € -441,284. Compared with financial year 2024, the result moved from € 32,448 to € 6,606. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Caution

€ -441,284

▲ € 6,606 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 6,606

▼ 80% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,374

▼ 92% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -453,684.

People and assets in 2025

Wage cost

€ 300,534

▲ 10% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,312

▼ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 349,807

▼ 13% vs 2024

€ 52,367 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 9,936

▲ € 9,876 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,823

▼ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -20,299 Gross margin 2022: € -20,299 First fiscal year in the series	€ 298,955 Gross margin 2023: € 298,955 ▲ € 319,254 vs 2022 (€ -20,299) Favourable step	€ 362,691 Gross margin 2024: € 362,691 ▲ 21% vs 2023 (€ 298,955) Favourable step	€ 356,779 Gross margin 2025: € 356,779 ▼ 2% vs 2024 (€ 362,691) Unfavourable step	▼ 2%
Profit after taxes	€ -154,733 Profit after taxes 2022: € -154,733 First fiscal year in the series	€ -79,128 Profit after taxes 2023: € -79,128 ▲ € 75,605 vs 2022 (€ -154,733) Favourable step	€ 32,448 Profit after taxes 2024: € 32,448 ▲ € 111,575 vs 2023 (€ -79,128) Favourable step	€ 6,606 Profit after taxes 2025: € 6,606 ▼ 80% vs 2024 (€ 32,448) Unfavourable step	▼ 80%
Equity	€ -401,209 Equity 2022: € -401,209 First fiscal year in the series	€ -480,337 Equity 2023: € -480,337 ▼ € 79,128 vs 2022 (€ -401,209) Unfavourable step	€ -447,890 Equity 2024: € -447,890 ▲ € 32,448 vs 2023 (€ -480,337) Favourable step	€ -441,284 Equity 2025: € -441,284 ▲ € 6,606 vs 2024 (€ -447,890) Favourable step	▲ € 6,606
Total debts	€ 1,256,349 Total debts 2022: € 1,256,349 First fiscal year in the series	€ 1,220,090 Total debts 2023: € 1,220,090 ▼ 3% vs 2022 (€ 1,256,349) Favourable step	€ 1,164,056 Total debts 2024: € 1,164,056 ▼ 5% vs 2023 (€ 1,220,090) Favourable step	€ 1,219,227 Total debts 2025: € 1,219,227 ▲ 5% vs 2024 (€ 1,164,056) Unfavourable step	▲ 5%
Cash	€ 13,370 Cash 2022: € 13,370 First fiscal year in the series	€ 3,707 Cash 2023: € 3,707 ▼ 72% vs 2022 (€ 13,370) Unfavourable step	€ 16,461 Cash 2024: € 16,461 ▲ € 12,754 vs 2023 (€ 3,707) Favourable step	€ 1,374 Cash 2025: € 1,374 ▼ 92% vs 2024 (€ 16,461) Unfavourable step	▼ 92%
Land & buildings	€ 705,378 Land & buildings 2022: € 705,378 First fiscal year in the series	€ 684,859 Land & buildings 2023: € 684,859 ▼ 3% vs 2022 (€ 705,378) Unchanged	€ 664,339 Land & buildings 2024: € 664,339 ▼ 3% vs 2023 (€ 684,859) Unchanged	€ 643,820 Land & buildings 2025: € 643,820 ▼ 3% vs 2024 (€ 664,339) Unchanged	▼ 3%
Retained profit	€ -413,609 Retained profit 2022: € -413,609 First fiscal year in the series	€ -492,737 Retained profit 2023: € -492,737 ▼ € 79,128 vs 2022 (€ -413,609) Unfavourable step	€ -460,290 Retained profit 2024: € -460,290 ▲ € 32,448 vs 2023 (€ -492,737) Favourable step	€ -453,684 Retained profit 2025: € -453,684 ▲ € 6,606 vs 2024 (€ -460,290) Favourable step	▲ € 6,606
Bank debt	€ 500,819 Bank debt 2022: € 500,819 First fiscal year in the series	€ 451,465 Bank debt 2023: € 451,465 ▼ 10% vs 2022 (€ 500,819) Favourable step	€ 401,150 Bank debt 2024: € 401,150 ▼ 11% vs 2023 (€ 451,465) Favourable step	€ 349,807 Bank debt 2025: € 349,807 ▼ 13% vs 2024 (€ 401,150) Favourable step	▼ 13%
Balance sheet total	€ 855,140 Balance sheet total 2022: € 855,140 First fiscal year in the series	€ 739,753 Balance sheet total 2023: € 739,753 ▼ 13% vs 2022 (€ 855,140) Unchanged	€ 716,167 Balance sheet total 2024: € 716,167 ▼ 3% vs 2023 (€ 739,753) Unchanged	€ 777,944 Balance sheet total 2025: € 777,944 ▲ 9% vs 2024 (€ 716,167) Unchanged	▲ 9%

Key figures of SciMedBE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SciMedBE?

What happened at SciMedBE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 6,606 (▼ 80% vs 2024). Source: NBB ↗
Apr 26, 2016 New establishment in Leuven. KBO
2016 Admir Hadzic became a director. NBB
Apr 26, 2016 Start of the company according to the CBE. KBO

In short

From € 154,733 loss in 2022 to € 6,606 profit in 2025.

Paid € 3,507 in corporate taxes since 2022.

Best year ever: 2024, with € 32,448 profit.

Original PDFs at the National Bank ↗

Management

Admir Hadzic

SciMedBE

Gebr. D-I-Lenaerts

Hadzic-Vandepitte Anaesthesiology

MedXPress.Pro

Behind SciMedBE is Admir Hadzic. Admir Hadzic is also behind Gebr. D-I-Lenaerts, Hadzic-Vandepitte Anaesthesiology, MedXPress.Pro and DR BLUES BELGIAN BREWS.

Directors

According to the 2025 annual accounts

Admir Hadzic

Director

Also active at: Gebr. D-I-Lenaerts, Hadzic-Vandepitte Anaesthesiology, MedXPress.Pro, DR BLUES BELGIAN BREWS

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Slachthuislaan 1 box 102

3000 Leuven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.

All companies at this address →

TELE PROTECTION - TELE SECRETARY SERVICE

COMTEL GROUP

SENAS

ATFINCO

€ 579,723 gross margin · 2025

MedXPress.Pro same network

€ 787,167 gross margin · 2025

+3 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0652.860.676

VAT number

BE 0652.860.676

Registered office

Slachthuislaan 1 bus 102, 3000 Leuven

Names & denominations

SciMedBE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 April 2016

Peppol

Active · Active since 31 Oct 2023

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Activiteiten van kuuroorden, sauna’s en stoombaden

Overige dienstverlenende activiteiten op het gebied van informatie

Sauna's, solaria, baden enz.

Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.

View on CBE Public ↗ Annual accounts (NBB) ↗

SciMedBE

Warning lights

Financials

What happened to SciMedBE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions